Publications

5808 Results

A phase II study of external beam radiation and chemotherapy with cisplatin/BCNU followed by BCNU alone of the treatment of incompletely resected high grade brain tumors: Preliminary results of a Southwest Oncology Group (SWOG) study (SWOG-9016).

Authors
S Petersdorf;C Upchurch;H Eyre;J Townsend;B Griffin;R Livingston;A Spence;M Berger
Journal / Conference
ASCO 12:176(#501)
Year
1993
Research Committee(s)
Brain
Study Number(s)
SWOG-9016

In the era of prostate specific antigen (PSA), is prostate acid phosphatase (PAP) necessary for staging prostate cancer? A Southwest Oncology Group study.

Authors
IM Thompson;EJ Zeidman;ED Crawford;AI Sagalowski;PF Schellhammer;RW deVere White;HB Grossman;E Klein;BA Lowe;AJ Bueschen;PT Scardino;RC Flanigan
Journal / Conference
American Urological Association Inc. 149:308A(#360)
Year
1993

Treatment of diffuse large-cell lymphoma: A summary of outcome for patients treated by the Southwest Oncology Group.

Authors
TP Miller;S Dahlberg
Journal / Conference
Malignant Lymphomas Including Hodgkins Disease 4:53-63
Year
1993
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7204/7205, SWOG-7426/7427, SWOG-7713/14

Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer.

Authors
EV Hannigan;S Green;DS Alberts;R O'Toole;E Surwit
Journal / Conference
Oncology 50(Suppl.2):2-9
Year
1993
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8412

NCAM (CD56)-positive malignant lymphoma.

Authors
WF Kern;CM Spier;TP Miller;TM Grogan
Journal / Conference
Leukemia & Lymphoma 12:1-10
Year
1993
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the t(8;21) (q22;q22).

Authors
JR Downing;DR Head;AM Curcio-Brint;MG Hulshof;TA Motroni;SC Raimondi;AJ Carroll;HA Drabkin;CL Willman;KS Theil;CI Civin;P Erikson
Journal / Conference
Blood 81(11):2860-2865
Year
1993
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8750, SWOG-9007, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120)

HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.

Authors
SP Hunger;DC Tkachuk;MD Amylon;MP Link;AJ Carroll;Jl Welborn;CL Willman;ML Cleary
Journal / Conference
Blood 81(12):3197-3203
Year
1993
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-9007, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120)

Cytolytic (TIA-1 +) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas.

Authors
J Diaz;R Tubbs;M Stoler;T Grogan
Journal / Conference
Leukemia & Lymphoma 9:91-94
Year
1993
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

Immunobiologic correlates of prognosis in lymphoma.

Authors
TM Grogan;TP Miller
Journal / Conference
Seminars in Oncology 20:58-74
Year
1993
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

A predictive model for aggressive non-Hodgkin's lymphoma. THE INTERNATIONAL NON-HODGKIN'S LYMPHOMA PROGNOSTIC FACTORS PROJECT.

Journal / Conference
NEJM 329(14):987-994
Year
1993
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8410, SWOG-8503, SWOG-8508